Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 150 (RNA5SP150) is classified as a **processed pseudogene** derived from the 5S ribosomal RNA gene family[4][2][6][8]. While canonical 5S ribosomal RNA is a vital structural component of the large ribosomal subunit involved in protein synthesis[1][3][7][9], **RNA5SP150 is a non-functional copy** (pseudogene) of the 5S rRNA gene. Pseudogenes like RNA5SP150 arise through duplication or retrotransposition events and usually lack the ability to code for a functional RNA due to mutations or loss of regulatory elements[6][8]. There is no evidence that RNA5SP150 plays an active biological role, interacts with drugs, or is a therapeutic target. Its clinical or biological significance is limited to use as a reference in genomic studies distinguishing coding genes from pseudogenes. While some pseudogenes are gaining attention in cancer research for their potential regulatory roles[10], **no functional or disease relevance has been established for RNA5SP150 to date**. No direct disease association; some pseudogene expressions are studied in cancer biology[10], but no evidence specific for RNA5SP150. This entry is **not a canonical drug target** (e.g., not a receptor, enzyme, transporter, or transcription factor). It is a processed RNA pseudogene, and not functional as a protein or regulatory RNA[2][4][6]. If the request intended a ribosomally functional 5S rRNA, or a protein target, those are distinct (see canonical 5S ribosomal RNA)[1][3][7][9]. "is_incorrect:true" because RNA5SP150 is not a typical therapeutic or targetable molecule. If searching for a functional ribosomal target, this is not the correct entity. **RNA, 5S ribosomal pseudogene 150** (RNA5SP150) is a human processed pseudogene derivative of the 5S ribosomal RNA gene, lacking functional or therapeutic relevance as a molecular drug target. It is non-coding, classified as a pseudogene, and presently has no established role in disease, therapy, or biomarker science[2][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 150 (RNA5SP150).